The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Cholesterol Efflux Pathways Suppress Inflammasome Activation, NETosis, and Atherogenesis
Open accessAbstract
Background: The CANTOS trial (Canakinumab Antiinflammatory Thrombosis Outcome Study) showed that antagonism of interleukin (IL)–1β reduces coronary heart disease in patients with a previous myocardial infarction and evidence of systemic inflammation, indicating that pathways required for IL-1β secretion increase cardiovascular risk. IL-1β and IL-18 are produced via the NLRP3 inflammasome in myeloid cells in response to cholesterol accumulation, but mechanisms linking NLRP3 inflammasome activation to atherogenesis are unclear. The cholesterol transporters ATP binding cassette A1 and G1 (ABCA1/G1) mediate cholesterol efflux to high-density lipoprotein, and Abca1/g1 deficiency in myeloid cells leads to cholesterol accumulation. Methods: To interrogate mechanisms connecting inflammasome activation with atherogenesis, we used mice with myeloid Abca1/g1 deficiency and concomitant deficiency of the inflammasome components Nlrp3 or Caspase-1/11 . Bone marrow from these mice was transplanted into Ldlr −/− recipients, which were fed a Western-type diet. Results: Myeloid Abca1/g1 deficiency increased plasma IL-18 levels in Ldlr −/− mice and induced IL-1β and IL-18 secretion in splenocytes, which was reversed by Nlrp3 or Caspase-1/11 deficiency, indicating activation of the NLRP3 inflammasome. Nlrp3 or Caspase-1/11 deficiency decreased atherosclerotic lesion size in myeloid Abca1/g1 -deficient Ldlr −/− mice. Myeloid Abca1/g1 deficiency enhanced caspase-1 cleavage not only in splenic monocytes and macrophages, but also in neutrophils, and dramatically enhanced neutrophil accumulation and neutrophil extracellular trap formation in atherosclerotic plaques, with reversal by Nlrp3 or Caspase-1/11 deficiency, suggesting that inflammasome activation promotes neutrophil recruitment and neutrophil extracellular trap formation in atherosclerotic plaques. These effects appeared to be indirectly mediated by systemic inflammation leading to activation and accumulation of neutrophils in plaques. Myeloid Abca1/g1 deficiency also activated the noncanonical inflammasome, causing increased susceptibility to lipopolysaccharide-induced mortality. Patients with Tangier disease, who carry loss-of-function mutations in ABCA1 and have increased myeloid cholesterol content, showed a marked increase in plasma IL-1β and IL-18 levels. Conclusions: Cholesterol accumulation in myeloid cells activates the NLRP3 inflammasome, which enhances neutrophil accumulation and neutrophil extracellular trap formation in atherosclerotic plaques. Patients with Tangier disease, who have increased myeloid cholesterol content, showed markers of inflammasome activation, suggesting human relevance.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“induction of cholesterol efflux from myeloid cells inhibits NLRP3 inflammasome activation73.”
From Inflammation and its resolution in atherosclerosis: mediators and therapeutic opportunities (2019) · cites this paper as [73]
In the citing paper
“In myeloid cells in which cholesterol efflux pathways have been genetically suppressed, accumulation of unesterified cholesterol in the cellular membranes without cholesterol crystal formation or lysosomal damage contributes to both priming and activation of the NLRP3 inflammasome73.”
From Inflammation and its resolution in atherosclerosis: mediators and therapeutic opportunities (2019) · cites this paper as [73]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
Ridker, P. M., Everett, B. M., Thuren, T., MacFadyen, J. G., Chang, W. H., Ballantyne, C., Fonseca, F., Nicolau, J., Koenig, W., Anker, S. D., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1707914 · Cited by 9,482
A role for mitochondria in nlrp3 inflammasome activation
Zhou, R., Yazdi, A. S., Menu, P., & Tschopp, J. (2011) · Nature · doi:10.1038/nature09663 · Cited by 5,602
Age-related clonal hematopoiesis associated with adverse outcomes
Jaiswal, S., Fontanillas, P., Flannick, J., Manning, A., Grauman, P. V., Mar, B. G., Lindsley, R. C., Mermel, C. H., Burtt, N., Chavez, A., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1408617 · Cited by 4,841
NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals
Duewell, P., Kono, H., Rayner, K. J., Sirois, C. M., Vladimer, G., Bauernfeind, F. G., Abela, G. S., Franchi, L., Nuñez, G., Schnurr, M., et al. (2010) · Nature · doi:10.1038/nature08938 · Cited by 4,026
Self-citationMechanisms and Functions of Inflammasomes
Lamkanfi, M., & Dixit, V. M. (2014) · Cell · doi:10.1016/j.cell.2014.04.007 · Cited by 2,579
Non-canonical inflammasome activation targets caspase-11
Kayagaki, N., Warming, S., Lamkanfi, M., Walle, L. V., Louie, S., Dong, J., Newton, K., Qu, Y., Liu, J., Heldens, S., et al. (2011) · Nature · doi:10.1038/nature10558 · Cited by 2,530
Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity
Henao-Mejia, J., Elinav, E., Jin, C., Hao, L., Mehal, W. Z., Strowig, T., Thaiss, C. A., Kau, A. L., Eisenbarth, S. C., Jurczak, M. J., et al. (2012) · Nature · doi:10.1038/nature10809 · Cited by 2,435
Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis
Khera, A. V., Cuchel, M., de la Llera-Moya, M., Rodrigues, A., Burke, M. F., Jafri, K., French, B. C., Phillips, J. A., Mucksavage, M. L., Wilensky, R. L., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1001689 · Cited by 1,943
Clonal hematopoiesis associated with TET2 deficiency accelerates atherosclerosis development in mice
Fuster, J. J., MacLauchlan, S., Zuriaga, M. A., Polackal, M. N., Ostriker, A. C., Chakraborty, R., Wu, C.-L., Sano, S., Muralidharan, S., Rius, C., et al. (2017) · Science · doi:10.1126/science.aag1381 · Cited by 1,536
Cholesterol, inflammation and innate immunity.
Tall, A. R., & Yvan-Charvet, L. (2015) · Nature Reviews Immunology · doi:10.1038/nri3793 · Cited by 1,479
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Items 101–200 of 331
Fidler, T. P., Dunbar, A. J., Kim, E., Hardaway, B., Pauli, J., Xue, C., Abramowicz, S., Xiao, T., O’Connor, K., Sachs, N., et al. (2024) · Nature Cardiovascular Research · doi:10.1038/s44161-023-00405-9 · Cited by 51
Self-citationDing, Q., Gao, Z., Chen, K., Zhang, Q., Hu, S., & Zhao, L. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.883410 · Cited by 49
Hsu, C.-C., Fidler, T. P., Kanter, J. E., Kothari, V. M., Kramer, F., Tang, J., Tall, A. R., & Bornfeldt, K. (2023) · Diabetes · doi:10.2337/db22-0962 · Cited by 49
Self-citationLipid metabolism in homeostasis and disease
Li, Z., Deng, W., Yang, L., Tang, C., Yue, J.-M., Monteiro, O., Baptista‐Hon, D. T., & Li, T. (2026) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02357-x · Cited by 58
Long noncoding RNAs: Potential therapeutic targets in cardiocerebrovascular diseases
Zhang, H., Лю, Б., Shi, X., & Sun, X. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107744 · Cited by 47
Self-citationJenkins, A. J., Grant, M. B., & Busik, J. V. (2022) · Diabetologia · doi:10.1007/s00125-022-05655-z · Cited by 46
Emerging Roles of Inflammasomes in Cardiovascular Diseases
Liao, Y., Liu, K., & Zhu, L. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.834289 · Cited by 53
Wu, C., Mao, J., Wang, X., Yang, R., Wang, C., Li, C., & Zhou, X. (2023) · Journal of Nanobiotechnology · doi:10.1186/s12951-023-02058-z · Cited by 44
The role of immune cells in different stages of atherosclerosis
He, C., Kim, H. I., Park, J. B., Guo, J., & Huang, W. (2024) · International Journal of Medical Sciences · doi:10.7150/ijms.94570 · Cited by 48
MicroRNA regulation of cholesterol metabolism
Citrin, K. M., Fernandez-Hernando, C. F., & Suárez, Y. (2021) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.14566 · Cited by 45
Endosomal Cholesterol in Viral Infections – A Common Denominator?
Glitscher, M., & Hildt, E. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.750544 · Cited by 39
Singh, P., Kumar, N., Singh, M., Kaur, M., Singh, G., Narang, A., Kanwal, A., Sharma, K., Singh, B., Napoli, M. D., et al. (2023) · Vaccines · doi:10.3390/vaccines11020261 · Cited by 44
Netosis and Inflammasomes in Large Vessel Occlusion Thrombi
Chen, S. H., Scott, X. O., Marcelo, Y. F., Almeida, V. W., Blackwelder, P. L., Yavagal, D. R., Peterson, E. C., Starke, R. M., Dietrich, W. D., Keane, R. W., et al. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.607287 · Cited by 41
das Neves, M. F., Batuca, J. R., & Alves, J. D. (2021) · Immunology · doi:10.1111/imm.13348 · Cited by 40
A Lipid Perspective on Regulated Pyroptosis
Qiu, Y., Shi, Y., Zhu, N., Zhang, S., Zhang, C., Gu, J. L., He, P., Dai, A., & Li, Q. (2023) · International Journal of Biological Sciences · doi:10.7150/ijbs.81017 · Cited by 44
Role of Gut Microbial Metabolites in Cardiovascular Diseases—Current Insights and the Road Ahead
Datta, S., Pasham, S., Sandeep, I. S., Boini, K. M., & Koka, S. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms251810208 · Cited by 42
Li, Q., Liu, S., Zhu, X., Mi, W., Mao‐Ying, Q., Wang, J., Yu, J. M., & Wang, Y.-Q. (2019) · Neuroscience · doi:10.1016/j.neuroscience.2019.05.025 · Cited by 40
High-Density Lipoproteins Decrease Proinflammatory Activity and Modulate the Innate Immune Response
Taborda, N. A., Blanquiceth, Y., Inchima, S. U., Latz, E., & Hernández, J. C. (2019) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2019.0029 · Cited by 40
HDL therapy today: from atherosclerosis, to stent compatibility to heart failure
Sirtori, C. R., Ruscica, M., Calabresi, L., Chiesa, G., Giovannoni, R., & Badimón, J. J. (2019) · Annals of Medicine · doi:10.1080/07853890.2019.1694695 · Cited by 41
Hafiane, A., & Daskalopoulou, S. S. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106157 · Cited by 41
The role of cholesterol and mitochondrial bioenergetics in activation of the inflammasome in IBD
Astorga, J., Gasaly, N., Dubois‐Camacho, K., la Fuente, M. D., Landskron, G., Faber, K. N., Urra, F. A., & Hermoso, M. A. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1028953 · Cited by 43
Sánchez-Azofra, A., Gu, W., Masso-Silva, J. A., Sánz-Rubio, D., Marín‐Oto, M., Cubero, P., Gil, A. V., Moya, E. A., Barnes, L. A., Mesarwi, O. A., et al. (2023) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.10600 · Cited by 39
Liu, W., Hardaway, B. D., Kim, E., Pauli, J., Wettich, J. L., Yalçınkaya, M., Hsu, C.-C., Xiao, T., Reilly, M. P., Tabas, I. A., et al. (2024) · Journal of Clinical Investigation · doi:10.1172/jci182939 · Cited by 37
Self-citationIntercepting IRE1 kinase‐FMRP signaling prevents atherosclerosis progression
Yıldırım, Z., Baboo, S., Hamid, S. M., Atici, A. E., Tufanlı, Ö., Robichaud, S., Emerton, C., Diedrich, J. K., Vatandaslar, H., Nikolos, F., et al. (2022) · EMBO Molecular Medicine · doi:10.15252/emmm.202115344 · Cited by 37
Self-citationTargeting pyroptosis to treat ischemic stroke: From molecular pathways to treatment strategy
Li, L., Shi, C., Dong, F., Xu, G., Lei, M., & Zhang, F. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.112168 · Cited by 38
Cao, L., Zhang, J., Yu, L., Yang, W. Q., Qi, W., Ren, R., Liu, Y., Hou, Y., Cao, Y., Li, Q., et al. (2025) · Journal of Clinical Investigation · doi:10.1172/jci186509 · Cited by 38
Neutrophils as an emerging therapeutic target and tool for cancer therapy
Subhan, M. A., & Torchilin, V. P. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.119952 · Cited by 38
O’Hagan, R., Berg, A., Hong, C. G., Parel, P. M., Mehta, N. N., & Teague, H. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.972140 · Cited by 36
Yalçınkaya, M., Liu, W., Xiao, T., Abramowicz, S., Wang, R., Wang, N., Westerterp, M., & Tall, A. R. (2024) · Journal of Lipid Research · doi:10.1016/j.jlr.2024.100534 · Cited by 41
Self-citationTraughber, C. A., Timinski, K., Prince, A., Bhandari, N., Neupane, K., Khan, M. R., Opoku, E., Opoku, E., Brubaker, G., Shin, J., et al. (2024) · Journal of the American Heart Association · doi:10.1161/jaha.123.033881 · Cited by 36
Impaired HDL Function Amplifies Systemic Inflammation in Common Variable Immunodeficiency
Macpherson, M. E., Halvorsen, B. L., Yndestad, A., Ueland, T., Mollnes, T. E., Berge, R. K., Rashidi, A., Otterdal, K., Gregersen, I., Kong, X. Y., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-45861-1 · Cited by 36
Single-cell RNA-Seq analysis of diabetic wound macrophages in STZ-induced mice
Ma, J., Song, R., Liu, C., Cao, G., Zhang, G. K., Wu, Z., Zhang, H., Sun, R. X., Chen, A., Wang, Y., et al. (2022) · Journal of Cell Communication and Signaling · doi:10.1007/s12079-022-00707-w · Cited by 34
Self-citationYang, X., Ma, Y., Chen, X., Zhu, J., Xue, W., & Ning, K. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.121867 · Cited by 36
Mutual Interplay of Host Immune System and Gut Microbiota in the Immunopathology of Atherosclerosis
Yeh, C., Chen, Y.-H., Liu, S.-F., Kao, H., Wu, M., Yang, K., & Wu, W. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21228729 · Cited by 37
The Neutrophil Secretome as a Crucial Link between Inflammation and Thrombosis
Blanch‐Ruiz, M. A., Ortega‐Luna, R., Martínez-Cuesta, M. Á., & Álvarez, Á. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22084170 · Cited by 41
Immune-based therapies in cardiovascular and metabolic diseases: past, present and future
Murphy, A. J., & Febbraio, M. A. (2021) · Nature reviews. Immunology · doi:10.1038/s41577-021-00580-5 · Cited by 35
The Role of Cytokines in Cholesterol Accumulation in Cells and Atherosclerosis Progression
Markin, A. M., Markina, Y. V., Bogatyreva, A. I., Tolstik, T. V., Chakal, D. A., Геннадьевич, Б. Д., & Charchyan, E. R. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24076426 · Cited by 39
Zhang, Y., Wang, Z.-E., Lu, Y., Sanchez, D. J., Li, J., Wang, L., Meng, X., Chen, J., Kien, T. T., Zhong, M., et al. (2024) · Advanced Science · doi:10.1002/advs.202403414 · Cited by 33
Cai, C., Zhu, H., Ning, X., Lin, L., Yang, B., Chen, S., Wang, L., Lu, X., & Gu, D. (2019) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2019.04.204 · Cited by 33
Mietus‐Snyder, M., Perak, A. M., Cheng, S. C., Hayman, L. L., Haynes, N., Meikle, P. J., Shah, S. H., & Suglia, S. F. (2023) · Circulation · doi:10.1161/cir.0000000000001185 · Cited by 32
Margiana, R., Alsaikhan, F., Al‐Awsi, G. R. L., Patra, I., Sivaraman, R., Fadhil, A. A., Al-Baghdady, H. F. A., Qasim, M. T., Hameed, N. M., Mustafa, Y. F., et al. (2022) · Cellular Signalling · doi:10.1016/j.cellsig.2022.110471 · Cited by 37
Avilkina, V., Chauveau, C., & Mhenni, O. G. (2021) · Bone · doi:10.1016/j.bone.2021.116232 · Cited by 33
Loss of sterol metabolic homeostasis triggers inflammasomes — how and why
Dang, E. V., & Cyster, J. G. (2018) · Current Opinion in Immunology · doi:10.1016/j.coi.2018.08.001 · Cited by 30
Dhawan, U. K., Vartak, T., Englert, H., Russo, S., Vasconcellos, L. R. C., Singhal, A., Chakraborty, R., Bhagat, K. K., McDonnell, C. O., Connolly, M., et al. (2025) · Circulation Research · doi:10.1161/circresaha.125.326353 · Cited by 35
Clinical Significance of Lipid Transport Function of ABC Transporters in the Innate Immune System
Kotlyarov, S. N., & Котлярова, А. А. (2022) · Membranes · doi:10.3390/membranes12111083 · Cited by 31
Role of inflammation and evidence for the use of colchicine in patients with acute coronary syndrome
Bulnes, J. F., González, L., Velásquez, L., Paz, O. M., Venturelli, P. M., & Martínez, G. (2024) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2024.1356023 · Cited by 30
Pérez-Olivares, L., & Soehnlein, O. (2021) · Cells · doi:10.3390/cells10081985 · Cited by 32
Xiao, S.-Y., Lv, Y.-H., Ji, Y., Dong, Y. W., Liu, M.-C., Li, T., Cui, X., & Hu, Y. (2025) · Molecular Biology Reports · doi:10.1007/s11033-025-11116-8 · Cited by 31
Participation of ABCA1 Transporter in Pathogenesis of Chronic Obstructive Pulmonary Disease
Kotlyarov, S. N. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22073334 · Cited by 27
Mauriello, A., Correra, A., Maratea, A. C., Caturano, A., Liccardo, B., Perrone, M. A., Giordano, A., Nigro, G., D’Andrea, A., & Russo, V. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14051652 · Cited by 29
HDL in Morbidity and Mortality: A 40+ Year Perspective
Tall, A. R. (2020) · Clinical Chemistry · doi:10.1093/clinchem/hvaa148 · Cited by 26
Self-citationThe Role of Long Non-Coding RNAs in Cardiovascular Diseases
Le, L. T. T., & Nhu, C. X. T. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241813805 · Cited by 26
Yan, Z., Xu, Y., Li, K., & Liu, L. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1272314 · Cited by 26
Metabolism: a potential regulator of neutrophil fate
Yipeng, Z., Chao, C., Li, R., Tingting, P., & Qu, H. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1500676 · Cited by 27
Dysregulation of cholesterol homeostasis in cancer pathogenesis
Mordzińska-Rak, A., Verdeil, G., Hamon, Y., Błaszczak, E., & Trombik, T. (2025) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-025-05617-9 · Cited by 30
The role of lipid metabolism in shaping the expansion and the function of regulatory T cells
Grimaldos, A. P., Bini, S., Pacella, I., Rossi, A., Costanzo, A. D., Minicocci, I., D’Erasmo, L., Arca, M., & Piconese, S. (2021) · Clinical & Experimental Immunology · doi:10.1093/cei/uxab033 · Cited by 25
Metabolism in atherosclerotic plaques: immunoregulatory mechanisms in the arterial wall
Forteza, M. J., & Ketelhuth, D. F. J. (2022) · Clinical Science · doi:10.1042/cs20201293 · Cited by 25
Mavrogiannis, E., Hagdorn, Q. A. J., Bazioti, V., Douwes, J. M., van der Feen, D. E., Oberdorf‐Maass, S. U., Westerterp, M., & Berger, R. M. F. (2022) · Pulmonary Circulation · doi:10.1002/pul2.12101 · Cited by 25
Self-citationRelationship between Cholesterol-Related Lipids and Severe Acute Pancreatitis: From Bench to Bedside
Zhou, X., Jin, S., Pan, J., Lin, Q., Yang, S., Lu, Y., Qiu, M., Ambe, P. C., Basharat, Z., Zimmer, V., et al. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12051729 · Cited by 27
Self-citationNeutrophil and NETosis Modulation in Traumatic Heterotopic Ossification
Nunez, J. H., Juan, C., Sun, Y., Hong, J. Y., Bancroft, A. C., Hwang, C. D., Medrano, J. M. R., Huber, A. K., Tower, R. J., & Lévi, B. (2023) · Annals of Surgery · doi:10.1097/sla.0000000000005940 · Cited by 25
Gu, C., Pang, B., Sun, S., An, C., Wu, M., Wang, N., Yuan, Y., & Liu, G. (2023) · Experimental Biology and Medicine · doi:10.1177/15353702231184217 · Cited by 27
Self-citationInnate Immune Pathways in Atherosclerosis—From Signaling to Long-Term Epigenetic Reprogramming
Aronova, A., Tosato, F., Naser, N., & Asare, Y. (2023) · Cells · doi:10.3390/cells12192359 · Cited by 24
Cholesterol Crystals as Triggers of NLRP3 Inflammasome Activation in Atherosclerosis
Yalçınkaya, M., & Tall, A. R. (2025) · Current Atherosclerosis Reports · doi:10.1007/s11883-025-01323-w · Cited by 30
Self-citationYang, Y., Karampoor, S., Mirzaei, R., Бороздкин, Л. Л., & Zhu, P. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.110546 · Cited by 24
Li, J., Liu, J., Yu, Y., Liu, Y., & Guan, X. (2022) · Molecular Biology Reports · doi:10.1007/s11033-022-07408-y · Cited by 23
Jia, Z., Zhang, X., Li, Z., Yan, H., Tian, X., Luo, C., Ma, K., Li, L., & Zhang, L. (2024) · Molecular Medicine Reports · doi:10.3892/mmr.2024.13259 · Cited by 23
Bonacina, F., Pirillo, A., Catapano, A. L., & Norata, G. D. (2019) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000642 · Cited by 23
Immunometabolism in atherosclerotic disorders
Fleetwood, A. J., Noonan, J. E., Gruta, N. L. L., Kallies, A., & Murphy, A. J. (2024) · Nature Cardiovascular Research · doi:10.1038/s44161-024-00473-5 · Cited by 28
Disordered haematopoiesis and cardiovascular disease: a focus on myelopoiesis
Dragoljevic, D., Westerterp, M., Veiga, C. B., Nagareddy, P. R., & Murphy, A. J. (2018) · Clinical Science · doi:10.1042/cs20180111 · Cited by 20
Self-citationXia, X.-D., Yu, X.-H., Chen, L., Xie, S., Feng, Y., Yang, R. Z., Zhao, Z.-W., Li, H., Wang, G., & Tang, C. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2020.158824 · Cited by 22
Zu, Z., Sheng, J., Qi, J., Yu, M., Zhang, Y., Zheng, T., Xiang, K., Wu, H., Lu, G., & Zhang, L. J. (2023) · Advanced Functional Materials · doi:10.1002/adfm.202212748 · Cited by 21
A neutrophil signature is strongly associated with increased cardiovascular risk in gout
Vedder, D., Gerritsen, M., Nurmohamed, M. T., van Vollenhoven, R., & Lood, C. (2020) · Lara D. Veeken · doi:10.1093/rheumatology/keaa712 · Cited by 21
Igel, E., Haller, A. M., Wolfkiel, P. R., Orr–Asman, M. A., Jaeschke, A., & Hui, D. Y. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.101106 · Cited by 20
Zhang, J., Ji, C., Zhai, X., Tong, H., & Hu, J. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.1038738 · Cited by 20
New Horizons for the Roles and Association of APE1/Ref-1 and ABCA1 in Atherosclerosis
Chen, W., Wang, S., & Xing, D. (2021) · Journal of Inflammation Research · doi:10.2147/jir.s330147 · Cited by 20
An, F., Liu, C., Wang, X., Tan, L., Fu, H., Bao, B., Cong, H., & Zhao, J. (2021) · BMC Cardiovascular Disorders · doi:10.1186/s12872-021-01894-x · Cited by 19
HDL Composition, Heart Failure, and Its Comorbidities
Diab, A., Ripoll, C. V., Guo, Z., & Javaheri, A. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.846990 · Cited by 24
Thakur, M., Evans, B. R., Schindewolf, M., Baumgärtner, I., & Döring, Y. (2021) · Cells · doi:10.3390/cells10071689 · Cited by 20
Xing, L., Kong, F., Wang, C., Li, L., Peng, S., Wang, D., & Li, C. (2023) · Food & Function · doi:10.1039/d3fo02740f · Cited by 18
High-Density Lipoprotein from Chronic Kidney Disease Patients Modulates Polymorphonuclear Leukocytes
Raupachova, J., Kopecky, C., & Cohen, G. (2019) · Toxins · doi:10.3390/toxins11020073 · Cited by 18
Exploring the Roles of Liver X Receptors in Lipid Metabolism and Immunity in Atherosclerosis
Endo‐Umeda, K., & Makishima, M. (2025) · Biomolecules · doi:10.3390/biom15040579 · Cited by 20
NETosis in myocardial ischemia‑reperfusion injury: From mechanisms to therapies (Review)
Zhang, Z., Wang, Y., Li, T., & Wang, H. (2025) · Biomedical Reports · doi:10.3892/br.2025.1991 · Cited by 18
Lorkowski, S. W., & Smith, J. D. (2022) · Biomedicines · doi:10.3390/biomedicines10010128 · Cited by 18
Adamidis, P. S., Pantazi, D., Moschonas, I. C., Liberopoulos, E. N., & Tselepis, A. D. (2024) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd11030072 · Cited by 19
Wang, X., Zhang, Y., Du, L., Jiang, Z., Guo, Y., Wang, K., Zhou, Y., Yin, X. L., & Guo, X. (2024) · iScience · doi:10.1016/j.isci.2024.109849 · Cited by 17
Wang, T., Dong, Y., Yao, L., Lü, F., Wen, C., Wan, Z., Fan, L., Li, Z., Bu, T., Wei, M., et al. (2022) · Bioactive Materials · doi:10.1016/j.bioactmat.2022.02.002 · Cited by 17
Yuan, Y., Sun, C., Liu, X., Hu, L., Wang, Z., Li, X., Zhang, J., Li, D., Zhang, X., Wu, M., et al. (2025) · Journal of Inflammation Research · doi:10.2147/jir.s507330 · Cited by 18
Mitochondrial DNA Dysfunction in Cardiovascular Diseases: A Novel Therapeutic Target
Xiang, M., Yang, M., Zhang, L., Ouyang, X., Sarapultsev, A., Luo, S., & Hu, D. (2025) · Antioxidants · doi:10.3390/antiox14091138 · Cited by 17
Huang, Z., Liang, N., Damdimopoulos, A., Fan, R., & Treuter, E. (2018) · The FASEB Journal · doi:10.1096/fj.201801123r · Cited by 16
Inhibition of Chikungunya Virus Replication in Primary Human Fibroblasts by Liver X Receptor Agonist
Hwang, J., Wang, Y., & Fikrig, E. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01220-19 · Cited by 16
Changes in HDL cholesterol, particles, and function associate with pediatric COVID-19 severity
Mietus‐Snyder, M., Suslovic, W., Delaney, M., Playford, M. P., Ballout, R. A., Barber, J. R., Otvos, J. D., DeBiasi, R. L., Mehta, N. N., & Remaley, A. T. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.1033660 · Cited by 15
An overview of the innate and adaptive immune system in atherosclerosis
Mohammad-Rezaei, M., Arefnezhad, R., Ahmadi, R., Abdollahpour‐Alitappeh, M., Mirzaei, Y., Arjmand, M., Ferns, G. A., Bashash, D., & Bagheri, N. (2020) · IUBMB Life · doi:10.1002/iub.2425 · Cited by 16
Inflammasome Activation and Neutrophil Extracellular Traps in Atherosclerosis
Karasawa, T., & Takahashi, M. (2025) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.rv22033 · Cited by 19
Chen, X., Du, Z., Guo, D., Guo, J., Sun, Q., Liu, T., Hua, K., Li, C., Wang, Y., & Wang, W. (2024) · Engineering · doi:10.1016/j.eng.2024.05.015 · Cited by 15
Self-citationTian, W., Qiu, H., He, Y., Zhang, M., Pan, X., Wang, Y., Shi, X., Wen, C., & Chen, J. (2024) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2024.118545 · Cited by 15
HBV‐Pol is crucial for HBV‐mediated inhibition of inflammasome activation and IL‐1β production
Lei, Q., Li, T., Kong, L., Lin, L., Ding, X., Wang, X., Zhang, X., & Qin, B. (2019) · Liver International · doi:10.1111/liv.14214 · Cited by 15
Yasuda, H., Takishita, Y., Mortia, A., Tsutsumi, T., Nakagawa, N., & Sato, E. F. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25168757 · Cited by 14
Jing, B., Gao, Y., Wang, L., Guo, F., Jiang, D., Qin, S., He, M., Bai, Y., An, R. F., Xie, M., et al. (2025) · Journal of Nanobiotechnology · doi:10.1186/s12951-025-03360-8 · Cited by 15
Cholesterol metabolism: physiological versus pathological aspects in intracerebral hemorrhage
Huang, R., Pang, Q., Zheng, L., Lin, J., Li, H., Wan, L., & Wang, T. (2024) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-23-01462 · Cited by 19
Genetic and epigenetic regulation of inflammasomes: Role in atherosclerosis
Yalçınkaya, M., & Tall, A. R. (2024) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2024.118541 · Cited by 15
Self-citation
Metadata
- Authors
- Westerterp, M., Fotakis, P., Ouimet, M., Bochem, A. E., Zhang, H., Molusky, M. M., Wang, W., Abramowicz, S., la Bastide-van Gemert, S., Wang, N., Welch, C. L., Reilly, M. P., Stroes, E. S., Moore, K. J., & Tall, A. R.
- Affiliations
- Division of Molecular Medicine (M.W., P.F., A.E.B., M.M.M., W.W., S.A., N.W., C.L.W., A.R.T.)
- University of Ottawa (CA)
- Amsterdam UMC Location University of Amsterdam (NL)
- Columbia University Irving Medical Center (US)
- Department of Epidemiology (S.l.B-v.G.), University of Groningen, University Medical Center Groningen, The Netherlands
- NYU Langone Health (US)
- Corresponding author
- Westerterp, Marit
- Fotakis, Panagiotis
- ORCID
- Venue
- Circulation
- Published
- 2018-08-28
- Volume
- 138
- Issue
- 9
- Pages
- 898-912
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- PMC
- PMC6160368
- OpenAlex
- W2795137969
- Cited by
- 331
- References
- 49
- Citations by year
- 2026: 37 · 2025: 40 · 2024: 41 · 2023: 47 · 2022: 45 · 2021: 45 · 2020: 36 · 2019: 28 · 2018: 11
- FWCI
- 10.67
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Circulation (publishedVersion)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (publishedVersion, other-oa)
- PubMed (publishedVersion)
- Pure Amsterdam UMC (publishedVersion, other-oa)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion, other-oa)
- Funders
- University of Ottawa
- York University
- Rijksuniversiteit Groningen
- Universiteit van Amsterdam
- Universitair Medisch Centrum Groningen
- National Institutes of Health
- National Heart, Lung, and Blood Institute (K24HL107643, R01HL113147, R01HL117334, R35HL135799, K99HL130574, R01HL107653, T32HL007343)
- National Center for Research Resources (S10RR027050)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
- Life Sciences › Immunology and Microbiology › Immunology › Atherosclerosis and Cardiovascular Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Keywords
- cholesterol efflux, ABCA1, ABCG1, NLRP3 inflammasome, caspase-1, caspase-11, IL-1β, IL-18, NETosis, atherogenesis, myeloid cells, non-canonical inflammasome, Tangier disease
- MeSH terms
- ATP Binding Cassette Transporter, Subfamily G, Member 1, NLR Family, Pyrin Domain-Containing 3 Protein, Animals, Cholesterol, Disease Models, Animal, Humans, Inflammation, Receptors, LDL, Spleen, Tangier Disease, Case-Control Studies, Cytokines, Mice, Knockout, Caspases, Caspase 1, Myeloid Cells, Atherosclerosis, Caspases, Initiator, Plaque, Atherosclerotic, Inflammasomes, ATP Binding Cassette Transporter 1, Extracellular Traps
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
